Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
Journal Information
Full Title: J Infect Dis
Abbreviation: J Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential conflicts of interests. C. A. C and E. H. are former employees of Janssen Vaccines & Prevention B.V. A. R. B., L.v. d. F., R. v. H., B. C., and J. S. are employees of Janssen Vaccines & Prevention B.V. V. K. is an employee of Janssen Infectious Diseases. E. D. P. and E. O. are former employees of Janssen Infectious Diseases. S. B. reports no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."
"Financial support. This work was supported by Janssen Vaccines & Prevention B.V. during all stages of the trial and its analysis and the development and publishing of the manuscript, including scientific writing assistance and statistical analyses. Financial support ."
"Clinical Trials Registration . NCT03502707."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025